News

BioAscent reports major revenue growth in 2022

01 February 2023


BioAscent has reported significant growth in 2022 – the fourth successive year of high double-digit growth since becomin...

Read more

Utilising Project Management Skills for Drug Discovery

24 January 2023


At BioAscent, we work with customers to deliver complex projects to accomplish their drug discovery goals. Projects are...

Read more

BioAscent promotes knowledge exchange through collaboration with University of Glasgow

09 December 2022


BioAscent has partnered with the University of Glasgow and Caldan Therapeutics to help support a Medical Research Scotla...

Read more

BioAscent recognised for exceptional performance

08 November 2022


BioAscent has been recognised for its exceptional performance in 2021.The laboratory-based drug-discovery contract resea...

Read more

Ada Lovelace Day 2022 – celebrating and inspiring women in STEM

11 October 2022


Ada Lovelace Day is an international day of celebration that aims to raise the profile of women in STEM to inspire other...

Read more

Four summers at BioAscent: A personal and academic development journey

22 September 2022


Kirsty Tinto recently completed her fourth summer working at BioAscent as our marketing and business development intern....

Read more

BioAscent launches Compound Connect web-based interface, allowing customers to securely manage their compound collections

11 September 2022


BioAscent has launched Compound Connect, a web-based interface that provides customers with secure access to a customise...

Read more

Christophe Auberger appointed to drive continued growth in the US

01 September 2022


BioAscent has welcomed experienced business development professional, Christophe Auberger to focus on its continued expa...

Read more

Advancements in generative AI: Implementation of an AI-assisted fragment library designer onto a widely accessible open-source platform

30 August 2022


BioAscent’s Associate Director of In Silico Discovery and Data Analysis, Dr Angelo Pugliese is co-author of a research a...

Read more

BioAscent invests in enhancing automated chromatography capabilities

21 August 2022


Delivering final compounds fast and efficiently to our customers is essential to help drive projects to meet key project...

Read more

Integrated Drug Discovery


Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact